• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

青少年和青年癌症患者:中枢神经系统肿瘤。

Adolescents and Young Adults With Cancer: CNS Tumors.

机构信息

Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.

Department of Psychology & Biobehavioral Sciences, St Jude Children's Research Hospital, Memphis, TN.

出版信息

J Clin Oncol. 2024 Feb 20;42(6):686-695. doi: 10.1200/JCO.23.01747. Epub 2023 Dec 8.

DOI:10.1200/JCO.23.01747
PMID:38064656
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11550794/
Abstract

Tumors of CNS are common in adolescents and young adults (AYAs). As the second leading cause of cancer-related death, CNS tumors in AYAs require improved clinical management. In this review, we discussed the current diagnostic approaches and recommended management strategies for malignant tumors in adult-type (IDH-mutant gliomas) and pediatric-type gliomas (pediatric high-grade gliomas), ependymoma and medulloblastoma, which commonly occur in AYAs. The impact of advanced molecular diagnostic approaches on the understanding of tumor biology of AYA CNS tumors is emphasized. To enhance participation in clinical trials, which poses a unique challenge in AYAs with CNS tumors, we propose encouraging referrals to neuro-oncology specialty care and improving collaboration between oncologists who care for both pediatric and adult patients. This will ensure better representation of AYA patients in research studies. Finally, we discussed the importance of considering neurocognitive and psychological function in AYAs with CNS tumor.

摘要

中枢神经系统肿瘤在青少年和年轻人(AYAs)中较为常见。作为癌症相关死亡的第二大原因,AYAs 中的中枢神经系统肿瘤需要改进临床管理。在这篇综述中,我们讨论了成人型(IDH 突变型神经胶质瘤)和儿童型神经胶质瘤(儿童高级别神经胶质瘤)、室管膜瘤和髓母细胞瘤等常见于 AYA 的恶性肿瘤的当前诊断方法和推荐的管理策略。强调了先进的分子诊断方法对 AYA 中枢神经系统肿瘤肿瘤生物学的理解的影响。为了加强临床试验的参与,这对患有中枢神经系统肿瘤的 AYA 提出了独特的挑战,我们建议鼓励向神经肿瘤学专业护理转诊,并改善同时照顾儿科和成年患者的肿瘤学家之间的合作。这将确保在研究中更好地代表 AYA 患者。最后,我们讨论了在患有中枢神经系统肿瘤的 AYA 中考虑神经认知和心理功能的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc7e/11550794/a134416d216d/nihms-2024897-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc7e/11550794/958581fc1ec9/nihms-2024897-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc7e/11550794/c4b1d4bc6f33/nihms-2024897-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc7e/11550794/a134416d216d/nihms-2024897-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc7e/11550794/958581fc1ec9/nihms-2024897-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc7e/11550794/c4b1d4bc6f33/nihms-2024897-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc7e/11550794/a134416d216d/nihms-2024897-f0003.jpg

相似文献

1
Adolescents and Young Adults With Cancer: CNS Tumors.青少年和青年癌症患者:中枢神经系统肿瘤。
J Clin Oncol. 2024 Feb 20;42(6):686-695. doi: 10.1200/JCO.23.01747. Epub 2023 Dec 8.
2
Central nervous system tumors in adolescents and young adults: A Society for Neuro-Oncology Consensus Review on diagnosis, management, and future directions.青少年和青年的中枢神经系统肿瘤:神经肿瘤学会关于诊断、管理及未来方向的共识性综述
Neuro Oncol. 2025 Jan 12;27(1):13-32. doi: 10.1093/neuonc/noae186.
3
Brain Tumor Imaging in Adolescents and Young Adults: 2021 WHO Updates for Molecular-based Tumor Types.青少年和年轻成人脑肿瘤成像:基于分子的肿瘤类型的 2021 年 WHO 更新。
Radiology. 2024 Feb;310(2):e230777. doi: 10.1148/radiol.230777.
4
Brain Tumors in Adolescents and Young Adults: A Review.青少年和青年成人脑肿瘤:综述
Semin Neurol. 2023 Dec;43(6):909-928. doi: 10.1055/s-0043-1776775. Epub 2023 Nov 10.
5
Treatment and Outcomes for Central Nervous System Tumors in Australian Adolescents and Young Adults: A Population-Based National Study.澳大利亚青少年和青年中枢神经系统肿瘤的治疗与结局:一项基于人群的全国性研究。
J Adolesc Young Adult Oncol. 2021 Apr;10(2):202-208. doi: 10.1089/jayao.2020.0074. Epub 2020 Aug 26.
6
Advances in the biology and treatment of pediatric central nervous system tumors.小儿中枢神经系统肿瘤的生物学与治疗进展
Curr Opin Pediatr. 2016 Feb;28(1):34-9. doi: 10.1097/MOP.0000000000000309.
7
The unique immune ecosystems in pediatric brain tumors: integrating single-cell and bulk RNA-sequencing.儿科脑肿瘤中的独特免疫生态系统:整合单细胞和批量 RNA 测序。
Front Immunol. 2023 Nov 29;14:1238684. doi: 10.3389/fimmu.2023.1238684. eCollection 2023.
8
Children's Oncology Group's 2023 blueprint for research: Central nervous system tumors.儿童肿瘤学组 2023 年研究蓝图:中枢神经系统肿瘤。
Pediatr Blood Cancer. 2023 Sep;70 Suppl 6(Suppl 6):e30600. doi: 10.1002/pbc.30600. Epub 2023 Aug 3.
9
Clinical Trial Enrollment Among Adolescent and Young Adults with Primary Central Nervous System Tumors Treated at the Dana-Farber Cancer Institute.在丹娜法伯癌症研究所接受治疗的原发性中枢神经系统肿瘤青少年和青年成人中的临床试验入组情况。
J Adolesc Young Adult Oncol. 2022 Dec;11(6):543-549. doi: 10.1089/jayao.2021.0187. Epub 2022 Jan 18.
10
Advances in the molecular classification of pediatric brain tumors: a guide to the galaxy.儿童脑肿瘤分子分类的进展:银河指南。
J Pathol. 2020 Jul;251(3):249-261. doi: 10.1002/path.5457. Epub 2020 Jun 10.

引用本文的文献

1
Gut-Brain-Microbiome Axis in the Regulation of Cancer Immune Escape and Immunotherapy in Tumors.肠道-脑-微生物群轴在肿瘤免疫逃逸及免疫治疗调控中的作用
Research (Wash D C). 2025 Sep 11;8:0885. doi: 10.34133/research.0885. eCollection 2025.
2
ELK4 induced upregulation of HOMER3 promotes the proliferation and metastasis in glioma via Wnt/β-catenin/EMT signaling pathway.ELK4诱导的HOMER3上调通过Wnt/β-连环蛋白/上皮-间质转化信号通路促进胶质瘤的增殖和转移。
Biol Direct. 2025 Apr 9;20(1):48. doi: 10.1186/s13062-025-00643-w.
3
Integrative multi-omic profiling of the neoantigen landscape of glioblastoma for the development of therapeutic vaccines reveals vast heterogeneity in immunogenic signatures.

本文引用的文献

1
Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma.沃拉西尼布治疗 IDH1 或 IDH2 突变型低级别胶质瘤。
N Engl J Med. 2023 Aug 17;389(7):589-601. doi: 10.1056/NEJMoa2304194. Epub 2023 Jun 4.
2
Unique molecular, clinical, and treatment aspects of gliomas in adolescents and young adults: a review.青少年和年轻成人脑胶质瘤的独特分子、临床和治疗特点:综述。
J Neurosurg. 2023 May 26;139(6):1619-1627. doi: 10.3171/2023.4.JNS221800. Print 2023 Dec 1.
3
Interactive Effects of Molecular, Therapeutic, and Patient Factors on Outcome of Diffuse Low-Grade Glioma.
对胶质母细胞瘤新抗原图谱进行整合多组学分析以开发治疗性疫苗,结果显示免疫原性特征存在巨大异质性。
Front Oncol. 2025 Mar 21;15:1507632. doi: 10.3389/fonc.2025.1507632. eCollection 2025.
4
Global, regional, and national burden of brain and central nervous system cancer: a systematic analysis of incidence, deaths, and DALYS with predictions to 2040.全球、区域和国家脑及中枢神经系统癌症负担:发病率、死亡率和伤残调整生命年的系统分析及到2040年的预测
Int J Surg. 2025 Jun 1;111(6):4033-4038. doi: 10.1097/JS9.0000000000002359. Epub 2025 Apr 1.
5
The spectrum of IDH- and H3-wildtype high-grade glioma subgroups occurring across teenage and young adult patient populations.青少年和年轻成年患者群体中出现的异柠檬酸脱氢酶(IDH)和组蛋白H3野生型高级别胶质瘤亚组的谱系。
Clin Cancer Res. 2025 Mar 10. doi: 10.1158/1078-0432.CCR-24-1256.
6
Evaluating KLHDC8A as a biomarker for glioma: impact on survival and proliferation through the Wnt/β-catenin pathway.评估KLHDC8A作为胶质瘤生物标志物:通过Wnt/β-连环蛋白途径对生存和增殖的影响。
Discov Oncol. 2024 Nov 30;15(1):732. doi: 10.1007/s12672-024-01625-6.
7
Neuroscience in peripheral cancers: tumors hijacking nerves and neuroimmune crosstalk.外周癌症中的神经科学:肿瘤劫持神经与神经免疫相互作用
MedComm (2020). 2024 Oct 31;5(11):e784. doi: 10.1002/mco2.784. eCollection 2024 Nov.
8
CBTRUS Statistical Report: American Brain Tumor Association & NCI Neuro-Oncology Branch Adolescent and Young Adult Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2016-2020.CBTRUS 统计报告:美国脑肿瘤协会和 NCI 神经肿瘤学分部 2016-2020 年在美国诊断的青少年和年轻成人原发性脑和其他中枢神经系统肿瘤。
Neuro Oncol. 2024 May 6;26(Supplement_3):iii1-iii53. doi: 10.1093/neuonc/noae047.
分子、治疗和患者因素对弥漫性低级别胶质瘤结局的交互作用。
J Clin Oncol. 2023 Apr 10;41(11):2029-2042. doi: 10.1200/JCO.21.02929. Epub 2023 Jan 4.
4
Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions.异柠檬酸脱氢酶(IDH)突变型脑胶质瘤:神经肿瘤学会(SNO)关于诊断、管理和未来方向的共识综述。
Neuro Oncol. 2023 Jan 5;25(1):4-25. doi: 10.1093/neuonc/noac207.
5
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2015-2019.美国 2015-2019 年确诊的原发性脑和其他中枢神经系统肿瘤 CBTRUS 统计报告。
Neuro Oncol. 2022 Oct 5;24(Suppl 5):v1-v95. doi: 10.1093/neuonc/noac202.
6
Redefining germline predisposition in children with molecularly characterized ependymoma: a population-based 20-year cohort.重新定义分子特征明确的室管膜瘤患儿中的种系易感性:一项基于人群的 20 年队列研究。
Acta Neuropathol Commun. 2022 Aug 25;10(1):123. doi: 10.1186/s40478-022-01429-1.
7
Extent of Tumor Resection and Survival in Pediatric Patients With High-Grade Gliomas: A Systematic Review and Meta-analysis.儿童高级别胶质瘤患者的肿瘤切除范围与生存:系统评价和荟萃分析。
JAMA Netw Open. 2022 Aug 1;5(8):e2226551. doi: 10.1001/jamanetworkopen.2022.26551.
8
Joint Final Report of EORTC 26951 and RTOG 9402: Phase III Trials With Procarbazine, Lomustine, and Vincristine Chemotherapy for Anaplastic Oligodendroglial Tumors.卡莫司汀、洛莫司汀和长春新碱化疗治疗间变性少突胶质细胞瘤的 EORTC 26951 和 RTOG 9402 联合最终报告:III 期试验
J Clin Oncol. 2022 Aug 10;40(23):2539-2545. doi: 10.1200/JCO.21.02543. Epub 2022 Jun 22.
9
Toxicity and Clinical Results after Proton Therapy for Pediatric Medulloblastoma: A Multi-Centric Retrospective Study.儿童髓母细胞瘤质子治疗后的毒性反应及临床结果:一项多中心回顾性研究
Cancers (Basel). 2022 Jun 1;14(11):2747. doi: 10.3390/cancers14112747.
10
Adolescent and young adult brain tumors: current topics and review.青少年和年轻成人脑肿瘤:当前的热点和综述。
Int J Clin Oncol. 2022 Mar;27(3):457-464. doi: 10.1007/s10147-021-02084-7. Epub 2022 Jan 22.